New research suggests oral cephalosporins may be a safer alternative to fluoroquinolones for treating kidney infections like pyelonephritis.

Cefepime-taniborbactam, an investigational beta-lactam and beta-lactamase inhibitor combination, was superior to meropenem for the treatment of hospitalized patients with complicated urinary tract ...

Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...

Researchers from Shaanxi Panlong Pharmaceutical Group Co. Ltd., Shaanxi Pioneer Biotech Co. Ltd. and affiliated organizations presented the discovery and preclinical characterization of novel ...

This narrative review in the British Journal of Biomedical Science examines emerging and recently approved therapeutic strategies to combat antimicrobial resistance, spanning new antibiotics, ...